The use of botulinum toxin type A for the treatment of facial spasm
Bol. Asoc. Méd. P. R
; 85(1/3): 7-11, Jan.-Mar. 1993.
Article
en En
| LILACS
| ID: lil-411617
Biblioteca responsable:
BR1.1
ABSTRACT
We describe our experience with the use of botulinum A toxin for the treatment of patients with facial spasms. Thirty four patients with blepharospasm, thirty eight with hemifacial spasms and three with spastic entropion were injected with the use of Botulinum A toxin. Length of follow up ranged from 6 to 60 months. The effect of toxin lasted an average of 12.1 weeks in patients with blepharospasm and 15.5 weeks in patients with hemifacial spasms. This difference in mean response was statistically significant (p = 0.0001). The most common side effect was ptosis and dry eyes. All side effects were transient in nature, lasting between three and twelve weeks. Botulinum toxin type A injections represent a good alternative for the treatment of facial spasms. It is a safe and effective office procedure. Most patients tolerate the procedure well. Its principal drawback is its transient effect and the need for repeated injections
Buscar en Google
Índice:
LILACS
Asunto principal:
Espasmo
/
Blefaroespasmo
/
Toxinas Botulínicas
/
Músculos Faciales
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Bol. Asoc. Méd. P. R
Asunto de la revista:
MEDICINA
Año:
1993
Tipo del documento:
Article